Xuezhen Ma
Impact in
-
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
-
- Antimicrobial Peptides and Activities
Papers in
-
- RNA modifications and cancer 5
- Cancer-related gene regulation 3
-
- Cancer-related molecular mechanisms research 3
- Co-authors
- Ju Fang (2 shared papers)Hui Zhao (1 shared paper)Lin Lü (1 shared paper)Yuan Yao (2 shared papers)Bin Wu (1 shared paper)Ke Zhang (1 shared paper)Zhihai Wang (1 shared paper)Shicui Zhang (1 shared paper)
- Journals
- PLoS ONE (2 papers)International Immunopharmacology (1 paper)Frontiers in Microbiology (1 paper)Blood (1 paper)Aging (1 paper)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Xuezhen Ma
20 papers receiving 293 citations
Peers
Comparison fields: 5 of 62
- Cancer Research 76
- Microbiology 20
- Molecular Biology 171
- Oncology 56
- Immunology 29
Countries citing papers authored by Xuezhen Ma
This map shows the geographic impact of Xuezhen Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xuezhen Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xuezhen Ma more than expected).
Fields of papers citing papers by Xuezhen Ma
This network shows the impact of papers produced by Xuezhen Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xuezhen Ma. The network helps show where Xuezhen Ma may publish in the future.
Co-authors
The 25 scholars most cited alongside Xuezhen Ma, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 24 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 47 | |
| 2 | 2024 | 35 | |
| 3 | 2024 | 32 | |
| 4 | ING5 inhibits epithelial-mesenchymal transition in breast cancer by suppressing PI3K/Akt pathway. | 2015 | 30 |
| 5 | 2017 | 25 | |
| 6 | 2015 | 24 | |
| 7 | 2023 | 22 | |
| 8 | 2017 | 19 | |
| 9 | 2017 | 17 | |
| 10 | 2022 | 8 | |
| 11 | 2024 | 6 | |
| 12 | 2022 | 6 | |
| 13 | 2011 | 6 | |
| 14 | 2022 | 5 | |
| 15 | 2024 | 4 | |
| 16 | 2025 | 3 | |
| 17 | 2024 | 2 | |
| 18 | 2023 | 2 | |
| 19 | 2024 | 1 | |
| 20 | 2025 | 1 |
About Xuezhen Ma
Xuezhen Ma is a scholar working on Molecular Biology, Cancer Research, Oncology, Physiology and Immunology, having authored 24 papers that have together received 295 indexed citations. Recurring topics across this work include RNA modifications and cancer (5 papers), Cancer-related gene regulation (3 papers), Cancer-related molecular mechanisms research (3 papers), Ferroptosis and cancer prognosis (2 papers), Antimicrobial Peptides and Activities (2 papers), Cancer Immunotherapy and Biomarkers (2 papers), Immune cells in cancer (2 papers) and Erythrocyte Function and Pathophysiology (2 papers). The work is most often cited by research in Cancer Research (76 citations), Microbiology (20 citations), Molecular Biology (171 citations), Oncology (56 citations) and Immunology (29 citations). Xuezhen Ma has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Ju Fang, Hui Zhao, Lin Lü, Yuan Yao, Bin Wu, Ke Zhang, Zhihai Wang, Hui Zhao, Shicui Zhang and Yuqing Feng. Their work appears in journals such as PLoS ONE, International Immunopharmacology, Frontiers in Microbiology, Blood and Aging.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.